Spectral AI (MDAI) Cash from Investing Activities (2021 - 2022)
Spectral AI (MDAI) reported Cash from Investing Activities of $251.2 million for Q4 2022, up 199.29% quarter-over-quarter from -$253.0 million in Q1 2021.
Spectral AI (MDAI) Cash from Investing Activities (2021 - 2022) Analysis & Trends
Spectral AI has reported Cash from Investing Activities for 2 years, with the latest figure at $251.2 million in Q4 2022.
- For the quarter ending Q4 2022, Cash from Investing Activities changed N/A year-over-year to $251.2 million; the trailing twelve-month figure through Dec 2022 stood at $251.2 million (up 199.29% YoY), and the FY2022 full-year result was $251.6 million, up 199.43% from the prior year.
- Cash from Investing Activities for Q4 2022 stood at $251.2 million, up from -$253.0 million in the prior quarter.
- The five-year high for Cash from Investing Activities was $251.2 million in Q4 2022, with the low at -$253.0 million in Q1 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -816.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -475.32 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -298.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -2.50 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | -217.20 Mn |
| 10 | Spectral AI | 57.48 Mn | 45.82 Mn | 2.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 251.21 Mn |
| Dec 31, 2022 | 251.21 Mn |
| Mar 31, 2021 | -253.00 Mn |
| Mar 31, 2021 | -253.00 Mn |